Affinomer is a biotech company focused on bringing Molecularly imprinted polymer (MIP) based biosensors to the point-of-care analytical landscape.

State-of-the-art, custom-designed synthetic affinity reagents crafted to meet the specific needs of your application.

Robust

Tunable

High Affinity

Applications

Due to the versatile nature of MIPs they have the potential to be integrated as "synthetic receptors" into lateral flow devices, biosensing platforms, and IVD (In Vitro Diagnostics) processing platforms for sample preparation, purification and even enrichment. Additionally, MIPs have demonstrated huge potential in more traditional chemical separation, catalysis, and even targeted drug release.

Biosensors

Lateral flow

Assay formats

Endless potential

Our receptors have the capability of being tailored towards a large range of targets, with these being just a few examples.

and more...

Meet the team...

Joseph Lowdon, PhD

CEO & Founder

Marc Collet

CCO

Anna Schoenherr

MIP Engineer

Collaborators and funders

Affinomer B.V. Oxfordlaan 70, 6229 EV, Maastricht info@affinomer.com Copyright 2023